Global Non-Hodgkin’s Lymphoma Treatment Market Size, Share & Forecast 2025–2034

The global non-Hodgkin’s lymphoma (NHL) treatment market reached a value of USD 13.44 Billion in 2024 and is projected to grow at a CAGR of 7.20% from 2025 to 2034, reaching USD 26.94 Billion by 2034. This growth is fueled by rising technological advancements and the expanding availability of innovative treatment options worldwide.